GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » Beneish M-Score

Hangzhou Minsheng Healthcare Co (SZSE:301507) Beneish M-Score : -2.63 (As of Apr. 22, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.63 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Hangzhou Minsheng Healthcare Co's Beneish M-Score or its related term are showing as below:

SZSE:301507' s Beneish M-Score Range Over the Past 10 Years
Min: -2.78   Med: -2.63   Max: -2.1
Current: -2.63

During the past 6 years, the highest Beneish M-Score of Hangzhou Minsheng Healthcare Co was -2.10. The lowest was -2.78. And the median was -2.63.


Hangzhou Minsheng Healthcare Co Beneish M-Score Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co Beneish M-Score Chart

Hangzhou Minsheng Healthcare Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - - - -2.10

Hangzhou Minsheng Healthcare Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.10 - -2.78 -2.63

Competitive Comparison of Hangzhou Minsheng Healthcare Co's Beneish M-Score

For the Drug Manufacturers - General subindustry, Hangzhou Minsheng Healthcare Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Minsheng Healthcare Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Minsheng Healthcare Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Hangzhou Minsheng Healthcare Co's Beneish M-Score falls into.


;
;

Hangzhou Minsheng Healthcare Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Hangzhou Minsheng Healthcare Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9427+0.528 * 1.0736+0.404 * 0.7834+0.892 * 1.0658+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9642+4.679 * -0.020736-0.327 * 1.0589
=-2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥54.2 Mil.
Revenue was 122.412 + 162.811 + 234.624 + 95.826 = ¥615.7 Mil.
Gross Profit was 58.577 + 92.812 + 147.368 + 56.177 = ¥354.9 Mil.
Total Current Assets was ¥1,251.8 Mil.
Total Assets was ¥1,708.0 Mil.
Property, Plant and Equipment(Net PPE) was ¥232.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥179.6 Mil.
Total Current Liabilities was ¥176.1 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0.3 Mil.
Net Income was 8.909 + 18.397 + 58.872 + 3.962 = ¥90.1 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -1.742 + -31.329 + 134.11 + 24.519 = ¥125.6 Mil.
Total Receivables was ¥53.9 Mil.
Revenue was 118.107 + 146.003 + 221.798 + 91.743 = ¥577.7 Mil.
Gross Profit was 78.575 + 84.687 + 141.656 + 52.59 = ¥357.5 Mil.
Total Current Assets was ¥1,168.9 Mil.
Total Assets was ¥1,638.9 Mil.
Property, Plant and Equipment(Net PPE) was ¥195.4 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥174.8 Mil.
Total Current Liabilities was ¥158.4 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(54.154 / 615.673) / (53.898 / 577.651)
=0.087959 / 0.093305
=0.9427

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(357.508 / 577.651) / (354.934 / 615.673)
=0.6189 / 0.576498
=1.0736

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1251.803 + 232.073) / 1708.018) / (1 - (1168.924 + 195.433) / 1638.903)
=0.131229 / 0.167518
=0.7834

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=615.673 / 577.651
=1.0658

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 195.433)) / (0 / (0 + 232.073))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(179.623 / 615.673) / (174.784 / 577.651)
=0.291751 / 0.302577
=0.9642

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.265 + 176.131) / 1708.018) / ((1.435 + 158.4) / 1638.903)
=0.103275 / 0.097526
=1.0589

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(90.14 - 0 - 125.558) / 1708.018
=-0.020736

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Hangzhou Minsheng Healthcare Co has a M-score of -2.63 suggests that the company is unlikely to be a manipulator.


Hangzhou Minsheng Healthcare Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Minsheng Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co Headlines

No Headlines